Bryan Bergin
Analyst
TD Cowen
Equibles does not estimate personal net worth.
About Bryan Bergin
Bryan Bergin is recorded as Analyst at TD Cowen. Bryan Bergin has spoken on 1 earnings call across 1 company, most recently for Genpact LTD on August 6, 2026. Definium Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other companies whose calls Bryan Bergin spoke on are classified in the Technology sector. Other leadership on record at Definium Therapeutics, Inc. includes Dr. Roger Crystal (CEO), Dr. Suzanne Bruhn (CEO), JR Rahn (CEO) and 7 others.
Bryan Bergin on recent calls
“So on the strategic prioritization that you're taking here, maybe the segment dynamics, just based on this conscious disruption of the business with the two-point DBS headwind this year and what sounds like a similar headwind next year, what does the target growth model kind of look on the other side of these changes?”
Affiliation history
-
TD Cowen
Analyst
Source not stated
Current -
Definium Therapeutics, Inc. (DFTX)
Source not stated
Current
Company network
Information Technology Services · Technology
1 appearance
Latest appearance 2026-08-06
View calls and events
Leadership on record at Definium Therapeutics, Inc.
- Dr. Roger Crystal CEO
- Dr. Suzanne Bruhn CEO
- JR Rahn CEO
- Robert Barrow CEO
- Stephen Hurst CEO
- Carol A. Vallone Chairman
- Brandi L. Roberts CFO
- David Gryska CFO
- Roger Adsett COO, Board Member
- Carrie F. Liao Chief Accounting Officer